We are live on ! Find out more
SGH

Sivik Global Healthcare Portfolio holdings

AUM $132M
1-Year Est. Return 24.1%
This Fund
S&P 500
This Quarter Est. Return
+2.91%
1 Year Est. Return
+24.1%
3 Year Est. Return
+53.78%
5 Year Est. Return
+97.1%
10 Year Est. Return
+690.63%
AUM
$368M
AUM Growth
+$183M
Cap. Flow
+$177M
Cap. Flow %
48.23%
Top 10 Hldgs %
48.89%
Holding
49
New
18
Increased
17
Reduced
7
Closed
3

Top Buys

Rank Stock Value
1
DGX icon
Quest Diagnostics
DGX
+$4.34M
2
BIO icon
Bio-Rad Laboratories Class A
BIO
+$4.26M
3
RVTY icon
Revvity
RVTY
+$4.24M
4
UNH icon
UnitedHealth
UNH
+$3.82M
5
RGEN icon
Repligen
RGEN
+$3.82M

Top Sells

Rank Stock Value
1
AZN icon
AstraZeneca
AZN
+$5.14M
2
EHC icon
Encompass Health
EHC
+$3.04M
3
BAX icon
Baxter International
BAX
+$3.03M
4
BSX icon
Boston Scientific
BSX
+$2.02M
5
ABT icon
Abbott
ABT
+$765K

Sector Composition

Rank Sector Weight
1 Healthcare 55.18%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
XBI icon
1
State Street SPDR S&P Biotech ETF
XBI
$10.2B
$20.7M 5.64%
250,000
– –
THC icon
2
Tenet Healthcare
THC
$21B
$15M 4.07%
85,000
+15,000
+21% +$2.26M
HCA icon
3
HCA Healthcare
HCA
$88.6B
$9.58M 2.61%
25,000
– –
MCK icon
4
McKesson
MCK
$103B
$9.53M 2.59%
13,000
+2,000
+18% +$1.41M
UHS icon
5
Universal Health Services
UHS
$10.4B
$9.51M 2.59%
52,500
+20,000
+62% +$3.61M
BSX icon
6
Boston Scientific
BSX
$72B
$8.59M 2.34%
80,000
-20,000
-20% -$2.02M
LLY icon
7
Eli Lilly
LLY
$1.06T
$8.57M 2.33%
11,000
+2,000
+22% +$1.55M
DHR icon
8
Danaher
DHR
$142B
$7.9M 2.15%
40,000
+5,000
+14% +$970K
CAH icon
9
Cardinal Health
CAH
$56.1B
$7.56M 2.06%
45,000
-5,000
-10% -$742K
SYK icon
10
Stryker
SYK
$130B
$7.52M 2.05%
19,000
+1,500
+9% +$561K
COR icon
11
Cencora
COR
$62.2B
$7.5M 2.04%
25,000
– –
ISRG icon
12
Intuitive Surgical
ISRG
$134B
$7.06M 1.92%
13,000
-1,000
-7% -$523K
MDT icon
13
Medtronic
MDT
$111B
$6.97M 1.9%
80,000
+5,000
+7% +$424K
NVO
14
Novo Nordisk
NVO
$209B
$6.9M 1.88%
100,000
+30,000
+43% +$2.04M
HUM icon
15
Humana
HUM
$45.8B
$6.6M 1.8%
27,000
+4,000
+17% +$997K
WAT icon
16
Waters Corp
WAT
$39.4B
$6.28M 1.71%
18,000
+1,000
+6% +$344K
GILD icon
17
Gilead Sciences
GILD
$165B
$5.54M 1.51%
50,000
+10,000
+25% +$1.06M
CI icon
18
Cigna
CI
$74.5B
$5.46M 1.48%
16,500
+4,000
+32% +$1.29M
ABT icon
19
Abbott
ABT
$186B
$5.33M 1.45%
39,200
-5,800
-13% -$765K
A icon
20
Agilent Technologies
A
$40.5B
$5.31M 1.44%
45,000
-5,000
-10% -$554K
UNH icon
21
UnitedHealth
UNH
$372B
$4.68M 1.27%
15,000
+10,000
+200% +$3.82M
SEM
22
DELISTED
Select Medical
SEM
$4.55M 1.24%
300,000
+100,000
+50% +$1.56M
DGX icon
23
Quest Diagnostics
DGX
$26.3B
$4.49M 1.22%
+25,000
New +$4.34M
RVTY icon
24
Revvity
RVTY
$12.8B
$4.35M 1.18%
+45,000
New +$4.24M
BIO icon
25
Bio-Rad Laboratories Class A
BIO
$9.29B
$4.34M 1.18%
+18,000
New +$4.26M
1
2

Similar funds

AFP
ATX Financial Planning Austin, Texas $132M AUM
TCPW
Twin City Private Wealth Winston-Salem, North Carolina $132M AUM 11.31% 1-Year Est. Return
GCM
Gunpowder Capital Management Towson, Maryland $132M AUM
PF
PlanVest Financial Gaithersburg, Maryland $131M AUM
DQRIM
Dale Q Rice Investment Management Vancouver, Washington $132M AUM 45.8% 1-Year Est. Return
PCGDR
Pangea Capital Gestao de Recursos Rio De Janeiro $131M AUM
AIP
Alapocas Investment Partners Beverly, Massachusetts $132M AUM 4.94% 1-Year Est. Return
ACM
Alcosta Capital Management San Ramon, California $131M AUM 34.7% 1-Year Est. Return

Sivik Global Healthcare's Q2 2025 Portfolio in Review

As of Q2 2025, Sivik Global Healthcare held 49 positions worth $368M, up 99% from $185M the previous quarter. Its ten largest holdings account for 49% of the portfolio.

Sivik Global Healthcare deployed $177M of net new capital in Q2 2025, opening 18 new positions and adding to 17 existing holdings. Its largest new stake was Quest Diagnostics: 25,000 shares worth $4.49M.

By sector, the portfolio is most concentrated in Healthcare at 55% of assets, down from 88% a quarter earlier.

On the sell side, the largest reduction was Encompass Health, an estimated $3.04M trimmed.

  • Sivik Global Healthcare's largest Q2 2025 buy was Quest Diagnostics: 25,000 shares worth $4.49M.
  • Sivik Global Healthcare added most to UnitedHealth in Q2 2025, an estimated $3.82M increase.
  • Sivik Global Healthcare's biggest Q2 2025 reduction was Encompass Health, cutting an estimated $3.04M.
  • Sivik Global Healthcare fully exited AstraZeneca in Q2 2025, selling an estimated $5.14M.
  • Sivik Global Healthcare's ten largest holdings make up 49% of its $368M portfolio in Q2 2025.
  • Sivik Global Healthcare opened 18 new positions and closed 3 in Q2 2025.
  • Sivik Global Healthcare's portfolio value rose 99% quarter-over-quarter to $368M.

Based on Sivik Global Healthcare's 13F filing for Q2 2025, filed 25 Jul 2025.